DT
AMPH icon

Diversified Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

Diversified Trust’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,018
Closed -$257K – 803
2021
Q4 		$257K Buy
+11,018
New +$225K 0.01% 686

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Diversified Trust's AMPH Position: Q1 2022 in Review

Diversified Trust sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 11,018 shares — an estimated $257K sold.

Diversified Trust first reported a position in AMPH in Q4 2021 and held it in 1 quarter. The position peaked at $257K in Q4 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Diversified Trust reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Diversified Trust sold 11,018 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $257K.
  • Diversified Trust first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Diversified Trust's Amphastar Pharmaceuticals position peaked at $257K in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Diversified Trust's 13F filing for Q1 2022, filed 7 Apr 2022.